As of the end of the first quarter of 2012, nearly 864,000 GeneXpert MTB/RIF rapid tuberculosis (TB) diagnostic cartridges had been procured under manufacturer Cephied’s concessional pricing mechanism.

Between 1990 and 2010, in countries with tuberculosis (TB) programs supported by USAID, TB death rates decreased by 29 percent, and TB prevalence rates declined by 14 percent.

Through spearheading innovative initiatives and providing financing for global health over the past five years, UNITAID has had a dramatic impact on millions of lives, using creative market approaches to increase access to treatment and diagnostics for HIV, malaria and tuberculosis.

Response by Medicines Control Council to letter by Global TB CAB on bedaquiline.

Research released by the Copenhagen Consensus Center identifies TB as a key priority for infectious disease control in terms of cost effectiveness and disease burden.

Open letter regarding Cepheid pricing of the GeneXpert machines and cartridges for high-burden settings in the public and private sectors.

Open letter to the Medicines Control Council of South Africa regarding compassionate use of bedaquiline for drug-resistant tuberculosis in South Africa.

Open letter to the Medicines Control Council and Ministry of Health on urgent need for compassionate use of bedaquiline for XDR-TB and pre-XDR-TB in South Africa.

This is a report of an online consultation and key informant interviews on childhood tuberculosis conducted by Citizen News Service (CNS) along with more than 50 partner organizations and networks in lead up to the World TB Day 2012.

ECDC and the European Respiratory Society (ERS) have developed 21 patient-centred standards that aim to guide clinicians and public health workers in their daily work to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe.